PHARMACEUTICAL TOXICOLOGY

PDE Calculation & HBEL Reports

HBEL and PDE Assessment for Pharmaceutical Substances. Search and access our comprehensive toxicology evaluations.

Pharmaceutical Substance Studies

Available

Betamethasone Valerate

Corticosteroid for topical use

CAS Number 2152-44-5
Doc Date Nov 9, 2025
Expires Nov 2028

Comprehensive HBEL and PDE assessment for Betamethasone Valerate, a potent corticosteroid used in various dermatological preparations.

Available

Neomycin Sulfate

Aminoglycoside antibiotic

CAS Number 1405-10-3
Doc Date Nov 9, 2025
Expires Nov 2028

Detailed HBEL and PDE evaluation for Neomycin Sulfate, an aminoglycoside antibiotic used in topical formulations.

Available

Nystatin

Polyene antifungal medication

CAS Number 1400-61-9
Doc Date Nov 9, 2025
Expires Nov 2028

Comprehensive assessment of HBEL and PDE for Nystatin, an antifungal agent used to treat candidiasis.

Available

Prednisolone

Synthetic corticosteroid

CAS Number 50-24-8
Doc Date Nov 9, 2025
Expires Nov 2028

Detailed HBEL and PDE evaluation for Prednisolone, a synthetic glucocorticoid used for anti-inflammatory and immunosuppressive therapies.

Frequently Asked Questions

Do you provide MACO calculations?

Yes, our reports include Maximum Allowable Carryover (MACO) limits based on the calculated PDE, batch sizes, and shared surface areas for your cleaning validation.

How long is a PDE report valid?

PDE reports should be reviewed periodically (typically every 3-5 years) or whenever significant new toxicological data becomes available, as per EU GMP Chapter 3 requirements.

Do you cover all pharmacological classes?

Yes, we have experience with potent compounds, hormones, cytotoxics, and antibiotics, deriving safe exposure limits for even the most hazardous substances.

Substance Not Found?

We can perform custom PDE/HBEL Assessments for your specific pharmaceutical substances.

Request Custom Study

Frequently Asked Questions

Why are PDE reports required for shared facilities?

According to EMA and PIC/S guidelines, manufacturers must determine health-based exposure limits (HBELs) like PDE to scientifically justify cleaning validation limits and ensure no cross-contamination risk between products in shared facilities.

What guidelines do you follow for PDE calculation?

Our toxicologists follow the EMA "Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities" and ICH Q3C/Q3D guidelines.

Can you calculate PDE for investigating new drugs (INDs)?

Yes, we can perform toxicological evaluations and determine provisional PDE limits for investigational new drugs based on available non-clinical and clinical data.

What is the difference between PDE and ADE?

PDE (Permitted Daily Exposure) and ADE (Acceptable Daily Exposure) are essentially the same concept used by different regulatory bodies (EMA places emphasis on PDE, while ISPE and some US contexts use ADE). Both represent the safe daily dose.